Feb 2 (Reuters) - Animal diagnostics maker IDEXX Laboratories (IDXX.O), opens new tab forecast 2026 revenue and profit slightly above Wall Street estimates on Monday, but said veterinary clinic visits ...
IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2025 earnings per share (EPS) of $3.08, up 18% year over year. The figure surpassed the Zacks Consensus Estimate by 5.17%. Comparable ...
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be downloaded here. The Fund delivered strong ...
IDEXX Laboratories delivered good Q4 results, but guidance below long-term target growth rates and ongoing weakness in vet visit volumes drove a selloff. Q4 revenue grew 14% with standout performance ...
WESTBROOK, Maine (AP) — WESTBROOK, Maine (AP) — Idexx Laboratories Inc. (IDXX) on Monday reported fourth-quarter net income of $248.2 million. The Westbrook, Maine-based company said it had profit of ...
IDEXX Laboratories Inc. (NASDAQ: IDXX) on Monday reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast. The animal health company reported fourth-quarter ...
IDEXX provided initial 2026 revenue guidance of $4.632 billion to $4.720 billion, representing 7.6% to 9.6% reported growth and 7% to 9% organic growth. CAG Diagnostics recurring revenues are expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results